PT  - JOURNAL ARTICLE
AU  - Masoli, Jane A.H.
AU  - Jeffries, Aaron
AU  - Temperton, Ben
AU  - Auckland, Cressida
AU  - Michelsen, Michelle
AU  - Warwick-Dugdale, Joanna
AU  - Manley, Robyn
AU  - Farbos, Audrey
AU  - Ellard, Sian
AU  - Knight, Beatrice
AU  - Bewshea, Claire
AU  - Sambles, Christine
AU  - Harrison, James
AU  - Bunce, Ben
AU  - Carr, Alexis
AU  - Hattersley, Andrew T.
AU  - Michell, Stephen Ll.
AU  - Studholme, David J.
TI  - Viral genetic sequencing identifies staff transmission of COVID-19 is important in a community hospital outbreak
AID  - 10.1101/2021.02.18.21250737
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.18.21250737
4099  - http://medrxiv.org/content/early/2021/02/19/2021.02.18.21250737.short
4100  - http://medrxiv.org/content/early/2021/02/19/2021.02.18.21250737.full
AB  - Background We have successfully used whole-genome sequencing to provide additional information for transmission pathways in infectious spread. We report and interpret genomic sequencing results in clinical context from a large outbreak of COVID-19 with 46 cases across staff and patients in a community hospital in the UK.Methods Following multiple symptomatic cases within a two-week period, all staff and patients were screened by RT-PCR and staff subsequently had serology tests.Results Thirty staff (25%) and 16 patients (62%) tested positive for COVID-19. Genomic sequencing data showed significant overlap of viral haplotypes in staff who had overlapping shift patterns. Patient haplotypes were more distinct from each other but had overlap with staff haplotypes.Conclusions This study includes clinical and genomic epidemiological detail that demonstrates the value of a combined approach. Viral genetic sequencing has identified that staff transmission of COVID-19 was important in this community hospital outbreak.Key pointsDetailed analysis of a large community hospital outbreak in older adults and staff with concurrent clinical and genomic data, including working patterns.Staff transmission was important in this community hospital outbreak.We found plausible associations between staff and patient cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCOG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute. JM is funded by the National Institute for Health Research (NIHR) (Doctoral Research Fellowship; DRF-2014-07-177). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Royal Devon and Exeter Tissue Bank (RDETB) Steering Committee as part of the ExCoSe study application: 26/3/20. RDETB Project Steering Committee approval numbers: STB63/CTB58. The RDETB is an ethically approved Research Tissue Bank (overarching ethical approval REC no 11/SW/0018) managed within the NIHR Exeter Clinical Research Facility. Responsibility for individual project specific approvals is delegated to the RDETB Steering Committee The genomic sequencing was performed as part of the COG-UK study. COG-UK genomic sequencing is conducted as part of surveillance for COVID-19 infections under the auspices of Section 251 of the NHS Act 2006. The COG-UK study protocol was approved by the Public Health England Research Ethics Governance Group (reference: R&D NR0195). Participants were identified during routine clinical practice and recruited via the Royal Devon and Exeter Tissue Bank (RDETB - ethical approval REC no 11/SW/0018) set up to facilitate research through the collection of spare clinical samples available at the time of routine procedures. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe sequence data are available under BioProject PRJEB37886 via https://www.ebi.ac.uk/ena/browser/view/PRJEB37886 https://www.ebi.ac.uk/ena/browser/view/PRJEB37886